Cardiologist. Inherited Cardiovascular Diseases. Cardiopatías y Aortopatías Familiares. @HUnivValdecilla H.U. Marqués de Valdecilla. Santander. 🇪🇸
Joined January 2020
- Tweets472
- Following114
- Followers218
- Likes1.2K
Luis Ruiz Guerrero retweeted
Cardiopulmonary exercise testing in contemporary cardiology: physiological insights, novel applications and evolving algorithms bit.ly/4c2zQIj
Luis Ruiz Guerrero retweeted
The proposed left atrium (LA) staging framework offers mechanistic insights into how the LA adapts to progressive diastolic dysfunction in #cvHCM. It is associated w/ a graded risk of NOAF and may help tailor AF surveillance strategies.
Learn more: bit.ly/4yB0K2l #JACC
Luis Ruiz Guerrero retweeted
Guidelines for the management of hereditary ATTR amyloidosis 2026 - PubMed pubmed.ncbi.nlm.nih.gov/4242…
Luis Ruiz Guerrero retweeted
ACACIA-HCM trial topline results - aficamten in nHCM. Incredibly proud and thankful to our patients and team for their commitment and hard work. This represents the first effective treatment for patients with nHCM. looking forward to seeing the full results.
#CardioTwitter
Luis Ruiz Guerrero retweeted
Danicamtiv enhanced cardiac myosin function in vitro and was generally well tolerated in #DCM. Echo findings suggest improved contractility, with strongest responses in #MYH7 and TTN cohorts jacc.org/doi/10.1016/j.jacc.… #JACC #cvDCM
Luis Ruiz Guerrero retweeted
Early-onset AF, especially without risk factors --> myocardial disease --> genetic evaluation
medrxiv.org/content/10.1101/…
#CardioTwitter
Luis Ruiz Guerrero retweeted
RBM20 cardiomyopathy carries a more significant burden at a younger age, and an accelerated course compared to TTN cardiomyopathy
pmc.ncbi.nlm.nih.gov/article…
#CardioTwitter
Luis Ruiz Guerrero retweeted
A deep dive into the mechanisms of ALPK3 associated HCM
#CardioTwitter
nature.com/articles/s41598-0…
Luis Ruiz Guerrero retweeted
📣New Consensus is out in #Europace
#EHRA2025
💊The diagnostic role of pharmacological provocation testing in cardiac electrophysiology💥
🔗 doi.org/10.1093/europace/eua…
@GiulioConte9 @Dominik_Linz @FraSantoroMD @AndyZhangMD @DavideMei93 @marcovitoloMD @LuigiDiBiaseMD
Luis Ruiz Guerrero retweeted
Limiting fluid intake may have no benefit for patients with #HeartFailure, according to findings from the FRESH-UP study presented during a Late-Breaking Clinical Trial session at #ACC25.
Check out the key findings ➡️ bit.ly/3DYGHEl
Luis Ruiz Guerrero retweeted
Late Gadolinium Enhancement in Early Repolarization Syndrome
heartrhythmjournal.com/artic…
Luis Ruiz Guerrero retweeted
📅 The A Coruña Hypertrophic Cardiomyopathy Congress is Back!
🗓 September 18-19, 2025
🔬 Experts from 🇦🇷 🇦🇺 🇩🇪 🇪🇸 🇫🇷 🇬🇧 🇮🇹 🇳🇱 🇵🇹 🇺🇸 @seccCFyGenetCV @secardiologia
🔗 hypertrophiccardiomyopathyac…
Luis Ruiz Guerrero retweeted
Low penetrance sarcomere variants (LowSVs) contribute to mild HCM alone but increase severity with high-risk variants. @neallakdawala @drjamesware @tikuowens @jodieingles27 @S2beri @sday_hcm @SeanLZheng @AdamHelmsMD ahajournals.org/doi/abs/10.1…
Luis Ruiz Guerrero retweeted
🧬 24% of patients with heritable arrhythmias & cardiomyopathies carry a disease-causing variant—but only 8% see changes in clinical management. How do we close the gap? Read the study: jacc.org/doi/10.1016/j.jacc.…
#JACC #Genetics #CardioScience #PrecisionMedicine #cvGenetics
Luis Ruiz Guerrero retweeted
Cardiopulmonary exercise testing (CPET) has a unique role in the assessment of cardiopulmonary disease. @BrazileTiffany and colleagues review key CPET variables, protocols and clinical indications. eviden.cc/4aC6uOt
ALT A visual representation of cardiopulmonary exercise testing applications.
Luis Ruiz Guerrero retweeted
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors. Learn more: nej.md/4h41K6k
ALT A diagram of a pragmatic approach to the diagnosis of heart failure with preserved ejection fraction.
Luis Ruiz Guerrero retweeted
🔬New in @JACCJournals: HCM diagnosis criteria show unexpected demographic bias. Study of 50,000+ hearts reveals current thresholds create 8:1 male-female ratio
Proposing demographic-adjusted thresholds to improve diagnosis🫀
authors.elsevier.com/a/1kPE5…
@UCL_ICS @NHSBartsHealth
Luis Ruiz Guerrero retweeted
I am very happy to end 2024 with the publication of our study "Validation of a hand-held ultrasound device in the evaluation of aortic stenosis".
Thanks to all the collaborators @raquelpbarquin #AdrianMargarida @HUnivValdecilla @IDIVALdecilla
link.springer.com/10.1007/s1…
Luis Ruiz Guerrero retweeted
This is nice work on an important question in EP. I have an idea about a subgroup. Mandrola theory of de novo AFlutter. If it occurs in pt w prior heart surgery, CTI likely enough. If no prior surgery, CTI + PVI better. #epeeps
LOE 👆= opinion. #EPeeps
Should we isolate the pulmonary veins in all patients with atrial flutter? Does PVI replace the need for cavitricuspid isthmus isolation? Provocative findings in systematic led by Daniel Gomes. Great collaboration @SergeBoveda , @DhirajGuptaBHRS , et al. #Afib #atrialfibrillation
